Navigation Links
NYU receives $490k NSF grant to promote women in the sciences
Date:9/9/2008

nt and advancement of women in science. The programs are designed to replace impediments to women's progress in science with a climate that provides greater support and that facilitates advancement at all levels.

These include mentoring and providing greater access to and opportunities for networking and visibility. To supplement the NSF award, FAS will create a family support initiative, which will provide resources to science faculty with family-care concerns, allowing them to conduct fieldwork and present research at out-of-town conferences. In addition, under the NSF award, NYU will expand its Challenge Grants, which will support research in areas where there are limited avenues for funding from existing sources.

As part of this effort, NYU will partner with local institutions, including Columbia University and CUNY's Hunter College, both of which have their own ADVANCE-PAID programs, to strengthen one another's initiatives through collaboration, coordination, and joint programs. For example, these institutions will work together to organize and sponsor conferences to present new results and advances in diversity studies (i.e., research on recruitment and mentoring), will share best practices and lessons learned from their existing programs, and will consider exchanges of graduate students and postdoctoral fellows to aid in recruitment and placement of women and underrepresented minorities.


'/>"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Childrens National researcher receives ACCP Distinguished Investigator Award
2. Duke Medicine physician-scientist receives National Medal of Science
3. UCSB chemistry professor receives top military award for life-saving gauze
4. Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
5. Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants
6. Artificial Gravity receives 2008 Life Science Book Award
7. Colorado Sen. Ken Salazar receives Soil Stewardship Award
8. Childrens Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach
9. Engineer receives $1.5M grant for nanoparticle cancer research
10. UC Riverside bioengineer receives high honor from chemical engineers
11. Pitt receives $2.5 million to simulate and analyze brain, immune system activity
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Newly discovered mechanism allows cells to change state 2More than fish bait: Worms unlock secrets to new epilepsy treatments 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4PDL BioPharma to Present at Oppenheimer 26amp 3B Co 20th Annual Healthcare Conference on November 4 2009 14619 1Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 1Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 2Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 3Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 4Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 5Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 6Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 7Endologix Reports 47 25 Third Quarter 2009 Revenue Growth 5765 8Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 1Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 2Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 3Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 4Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 5Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 6Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 7Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 8Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 9Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 10Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 11Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 12Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 13Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 14Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 15Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 16Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 17Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 18Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 19Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 20Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 21Cephalon Net Sales Increase 9 25 and Net Cash from Operations Surpasses 24200 Million in the Third Quarter 2009 5760 22